CATALYST BIOSCIENCES INC's ticker is CBIO and the CUSIP is 14888D208. A total of 47 filers reported holding CATALYST BIOSCIENCES INC in Q1 2020. The put-call ratio across all filers is 0.69 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $250,000 | -82.5% | 60,755 | -81.4% | 0.01% | -92.4% |
| Q1 2020 | $1,425,000 | +1.4% | 326,008 | +170.5% | 0.17% | +138.9% |
| Q2 2018 | $1,406,000 | -70.0% | 120,500 | -33.6% | 0.07% | -63.8% |
| Q1 2018 | $4,684,000 | +175.9% | 181,547 | +45.8% | 0.20% | +123.6% |
| Q4 2017 | $1,698,000 | – | 124,500 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 3,076,376 | $13,321,000 | 6.97% |
| 22NW, LP | 1,429,242 | $6,189,000 | 1.66% |
| Ghost Tree Capital, LLC | 1,000,000 | $4,330,000 | 1.19% |
| ACUTA CAPITAL PARTNERS, LLC | 685,000 | $2,966,000 | 1.18% |
| Sio Capital Management, LLC | 623,892 | $2,701,000 | 0.67% |
| Parkman Healthcare Partners LLC | 393,449 | $1,704,000 | 0.37% |
| Nantahala Capital Management | 2,531,360 | $10,961,000 | 0.31% |
| AlphaCentric Advisors LLC | 182,500 | $790,000 | 0.22% |
| Ikarian Capital, LLC | 581,200 | $2,518,000 | 0.20% |
| Tibra Equities Europe Ltd | 79,200 | $343,000 | 0.11% |